Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections

Despite efforts made to develop efficient preventive strategies, infections with influenza A viruses (IAV) continue to cause serious clinical and economic problems. Current licensed human vaccines are mainly inactivated whole virus particles or split-virion administered via the parenteral route. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Calzas, Cynthia, Chevalier, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650573/
https://www.ncbi.nlm.nih.gov/pubmed/31379823
http://dx.doi.org/10.3389/fimmu.2019.01605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650573/
https://www.ncbi.nlm.nih.gov/pubmed/31379823
http://dx.doi.org/10.3389/fimmu.2019.01605

Ejemplares similares